LumiraDx Ltd
NASDAQ:LMDX
LumiraDx Ltd
NASDAQ:LMDX
Price:
0.016 USD
Updated:
May 6, 2024
LumiraDx Ltd
Cash from Financing Activities
|
LumiraDx Ltd
Cash from Financing Activities Peer Comparison
Comparables:
SN
LIVN
EKF
AGL
CREO
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Cash from Financing Activities
$165.3m
|
CAGR 3-Years
33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Smith & Nephew PLC
LSE:SN
|
Cash from Financing Activities
-$200m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Cash from Financing Activities
$21.5m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Cash from Financing Activities
-£3.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-9%
|
|
|
Angle PLC
LSE:AGL
|
Cash from Financing Activities
£17.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Cash from Financing Activities
£522k
|
CAGR 3-Years
-78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LumiraDx Ltd's Cash from Financing Activities?
Cash from Financing Activities
165.3m
USD
165.3m
USD
Based on the financial report for Dec 31, 2022, LumiraDx Ltd's Cash from Financing Activities amounts to 165.3m USD.
What is LumiraDx Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
33%
33%
Over the last year, the Cash from Financing Activities growth was -25%. The average annual Cash from Financing Activities growth rates for LumiraDx Ltd have been 33% over the past three years .
You don't have any saved screeners yet
